MarginsXMarginsX
Home › Markets › Industrials › EYPT

EyePoint Inc. (EYPT)

EYPT trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.3076
+0.52% on the day
Market cap
$35.0M
Nano cap
Revenue · 2025
$31.4M
-27.5% on 2024
Net income · 2025
-$232.0M
-739.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1314102/000119312526093917/0001193125-26-093917-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerEYPT on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001314102
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$31.4M
Net income-$232.0M
Operating income-$243.4M
Net margin-739.4%
Operating margin-776.0%
Revenue growth-27.5%
Cash$101.8M
Total assets$364.0M
P/E (computed)Net income was not positive
P/S (computed)1.1×

Warning signs

Cash runway
3.4 months
$83.2M cash at September 30, 2026
Share count, 1 year
+37.4%
2025-10-30 to 2026-11-06 · +222.2% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
-$2.0M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions and events raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-12
Cash and burn$83.2M cash; operating cash flow -$73.7M a quarter.Report 2026-09-30
Shares outstanding113,782,597 (2026-11-06); 82,787,220 a year earlier; 35,309,432 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $72K, sold $2.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
$756K-$95.6M-$86.8M$83.2MNo debt tags$2.6M10-Q 2026-11-12
Q4 2026
2026-06-30
$507K-$94.5M-$62.3M$110.5MNo debt tags$2.8M10-Q 2026-08-05
Q3 2026
2026-03-31
$696K-$84.8M-$80.5M$77.7MNo debt tags$7.6M10-Q 2026-05-07
Q2 2026
2025-12-31
$620K-$67.6M-$65.0M$101.8MNo debt tags$31.4M10-K 2026-03-05
Q1 2026
2025-09-30
$966K-$59.7M-$59.4M$74.6MNo debt tags$42.3M10-Q 2026-11-12
Q4 2025
2025-06-30
$5.3M-$59.4M-$62.6M$71.1MNo debt tags$51.9M10-Q 2026-08-05
Q3 2025
2025-03-31
$24.5M-$45.2M-$53.1M$85.2MNo debt tags$56.0M10-Q 2026-05-07
Q2 2025
2024-12-31
$11.6M-$41.4M-$35.8M$99.7MNo debt tags$43.3M10-K 2026-03-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-11-06
Latest annual report10-K2026-03-05
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 1,005 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-13.9%
1 month-89.9%
3 months-97.7%
Year to date-98.3%
1 year-97.3%
From 52-week high-98.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
PRPOPrecipio Inc.$19.96-9.81%$35.8M
RPIDRapid Micro Biosystems Inc.$0.7400+13.67%$37.1M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
CIRCCircle8 Group Inc.$0.1702-7.30%$20.0M
SEERSeer Inc.$1.48-5.73%$82.6M
BNGOBionano Genomics Inc.$0.9400-6.00%$13.1M
QTRXQuanterix Corporation$2.84-3.07%$134.8M
ASTCAstrotech Corporation (DE)$3.76-10.48%$8.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier